Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
We compare index funds and target date funds for retirement to help you decide based on time horizon, risk tolerance, costs, and tax considerations.
26,044 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
New data shows Americans who reach 65 can expect nearly 20 more years of life. That longer horizon is forcing retiree...
When required minimum distributions start at 73, retirees with over $1.2 million in a traditional 401(k) can face a s...
Retirees report regret after Roth conversions trigger a sizable upfront tax hit and later Medicare premium increases,...
Retirees face a surprising two-year lag between last-year earnings and Medicare premium changes, even when Social Sec...
A 73-year-old retiree with $1.6 million in a traditional 401(K) confronts a sizable first required minimum distributi...
When a person is widowed twice, survivor benefits from multiple spouses do not stack. The Social Security Administrat...
A growing scam targets seniors through fake tech support calls, threatening retirement security. This guide explains ...
A 76-year-old retiree doubles a spouse’s 401(k) via rollover, drawing attention to how your spouse kinds benefits can...
A last-minute cancellation can hit wallets as hard as plans. This guide breaks down how to navigate refunds, recover ...
A dividend-focused ETF has been stealing the spotlight by delivering solid gains with steady income. This guide expla...
Is there a smarter way to diversify beyond the U.S.? This article explores whether could this international best ETF ...